Skip to main content

Advertisement

SpringerLink
Log in

SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013

  • Clinical Guides in Oncology
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Nasopharyngeal carcinoma cases are not frequently encountered in our environment. Local stages are treated with radiotherapy. For advanced local stages, the association of chemotherapy with radiotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum-based chemotherapy and patients may achieve a long survival time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide IARC CancerBase N. 5, version 2.0. Lyon:IARC Press; 2004.

  2. Shanmugaratnam K, Sobon LH. The World Health Organitation histological classification of tumours of the upper repiratory tract and ear. A comentary on the second edition. Cancer. 1993;71:2689–97.

    Article  PubMed  CAS  Google Scholar 

  3. Xeng XK, Chen LH, Wang OS, Fu FB. Influence of (18F) fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;65(4):1020–5.

    Article  Google Scholar 

  4. Classification TNM. En: American joint committee on cancer: AJCC cancer staging handbook. 7th ed. New York: Springer; 2010.

    Google Scholar 

  5. Fu KK. Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma. Semin Radiat Oncol. 1998;8(4):247–53.

    Article  PubMed  CAS  Google Scholar 

  6. Thephamongkol K, Zhou J, Browman G, Wong RKW, Chan JCK, Zeng Y, et al. Chemo-radiotherapy versus radiotherapy alone for nasopharyngeal carcinoma: a meta-analysis of 78 randomized controlled trials from English and not-English databases (abstract). Proc Am Soc Clin Oncol. 2004;23:491a.

    Google Scholar 

  7. Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT et al. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev. 2006;8(4):1–24.

    Google Scholar 

  8. Bae WK, Hwang JE, Shim HJ, Cho SH, Lee JK, Lim SC, et al. Phase II study of docetaxel, cisplatin, and 5:FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer. Cancer Chemother Pharmacol. 2010;65:589–95.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest relating to the publication of this manuscript.

Author information

Authors and Affiliations

  1. Servicio de Oncología Médica, Institut Català d’Oncologia-L’Hospitalet, Barcelona, Spain

    R. Mesía

  2. Servicio de Oncología Médica, Hospital General Universitario La Fe, Valencia, Spain

    M. Pastor

  3. Servicio de Oncología Médica, Hospital Clinic de Barcelona, Barcelona, Spain

    J. J. Grau

  4. Servicio de Oncología Médica, Hospital Universitario de Salamanca, P° de San Vicente, 58-182, 37007, Salamanca, Spain

    E. del Barco

Authors
  1. R. Mesía
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Pastor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. J. Grau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. del Barco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. del Barco.

Appendix: Clinical Guideline Working Group on behalf of the Spanish Society of Medical Oncology (SEOM) Executive Committee 2011–2013

Appendix: Clinical Guideline Working Group on behalf of the Spanish Society of Medical Oncology (SEOM) Executive Committee 2011–2013

Juan Jesús Cruz, Pilar Garrido, Agustí Barnadas, Pablo Borrega, Francisco Javier Barón, Elvira del Barco, Rocio García-Carbonero, Jesús Garcia-Mata, Encarnación Gonzalez, Pilar Lianes, Antonio Llombart y Fernando Rivera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mesía, R., Pastor, M., Grau, J.J. et al. SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013. Clin Transl Oncol 15, 1025–1029 (2013). https://doi.org/10.1007/s12094-013-1094-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-013-1094-1

Keywords

Search

Navigation